Real-World Evidence of COVID-19 Patients' Data Quality in the Electronic Health Records.
Samar BinkhederMohammed Ahmed AsiriKhaled Waleed AltowayanTurki Mohammed AlshehriMashhour Faleh AlzarieRaniah N AldekhyyelIbrahim A AlmaghlouthJwaher A AlmulhemPublished in: Healthcare (Basel, Switzerland) (2021)
Despite the importance of electronic health records data, less attention has been given to data quality. This study aimed to evaluate the quality of COVID-19 patients' records and their readiness for secondary use. We conducted a retrospective chart review study of all COVID-19 inpatients in an academic healthcare hospital for the year 2020, which were identified using ICD-10 codes and case definition guidelines. COVID-19 signs and symptoms were higher in unstructured clinical notes than in structured coded data. COVID-19 cases were categorized as 218 (66.46%) "confirmed cases", 10 (3.05%) "probable cases", 9 (2.74%) "suspected cases", and 91 (27.74%) "no sufficient evidence". The identification of "probable cases" and "suspected cases" was more challenging than "confirmed cases" where laboratory confirmation was sufficient. The accuracy of the COVID-19 case identification was higher in laboratory tests than in ICD-10 codes. When validating using laboratory results, we found that ICD-10 codes were inaccurately assigned to 238 (72.56%) patients' records. "No sufficient evidence" records might indicate inaccurate and incomplete EHR data. Data quality evaluation should be incorporated to ensure patient safety and data readiness for secondary use research and predictive analytics. We encourage educational and training efforts to motivate healthcare providers regarding the importance of accurate documentation at the point-of-care.
Keyphrases
- electronic health record
- sars cov
- healthcare
- clinical decision support
- coronavirus disease
- patient safety
- adverse drug
- big data
- quality improvement
- pulmonary embolism
- ejection fraction
- emergency department
- mass spectrometry
- deep learning
- prognostic factors
- end stage renal disease
- artificial intelligence
- health insurance